[HTML][HTML] Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

…, S Acheampong, J Acheson, A Acosta, C Acton… - The Lancet, 2021 - thelancet.com
Background In this study, we aimed to evaluate the effects of tocilizumab in adult patients
admitted to hospital with COVID-19 with both hypoxia and systemic inflammation. Methods This …

[HTML][HTML] Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

…, S Acheampong, J Acheson, A Acosta, C Acton… - The Lancet, 2021 - thelancet.com
Background Many patients with COVID-19 have been treated with plasma containing anti-SARS-CoV-2
antibodies. We aimed to evaluate the safety and efficacy of convalescent plasma …

[HTML][HTML] Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

…, J Acheson, S Achieng, A Acosta, R Acquah, C Acton… - The Lancet, 2022 - thelancet.com
Background We aimed to evaluate the use of baricitinib, a Janus kinase (JAK) 1–2 inhibitor,
for the treatment of patients admitted to hospital with COVID-19. Methods This randomised, …

[HTML][HTML] Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

…, S Acheampong, J Acheson, A Acosta, C Acton… - The Lancet, 2022 - thelancet.com
Background Casirivimab and imdevimab are non-competing monoclonal antibodies that bind
to two different sites on the receptor binding domain of the SARS-CoV-2 spike glycoprotein…

[HTML][HTML] Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

…, D Acharya, J Acheson, A Acosta, C Acton… - The Lancet, 2021 - thelancet.com
Background Azithromycin has been proposed as a treatment for COVID-19 on the basis of its
immunomodulatory actions. We aimed to evaluate the safety and efficacy of azithromycin in …

[HTML][HTML] Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

…, S Acheampong, J Acheson, A Acosta, C Acton… - The Lancet, 2022 - thelancet.com
Background Aspirin has been proposed as a treatment for COVID-19 on the basis of its anti-thrombotic
properties. We aimed to evaluate the efficacy and safety of aspirin in patients …

[HTML][HTML] Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised …

…, J Acheson, S Achieng, A Acosta, R Acquah, C Acton… - The Lancet, 2023 - thelancet.com
Background Low-dose corticosteroids have been shown to reduce mortality for patients with
COVID-19 requiring oxygen or ventilatory support (non-invasive mechanical ventilation, …

Mental health problems among childbearing women: historical perspectives and social determinants

J Fisher, C Acton, H Rowe - Motherhood in the face of trauma: Pathways …, 2018 - Springer
Mental health problems among women who are pregnant, or who have recently given birth
occur in social, cultural, economic and political contexts. These influence their life …

[HTML][HTML] Examination of national survey data regarding academic foundation training during the COVID-19 pandemic second wave

CG Underwood, C Acton, B Sharma… - Future Healthcare …, 2022 - ncbi.nlm.nih.gov
Aim We aimed to examine the effect of the second wave of the COVID-19 pandemic on
Academic Foundation Programme (AFP) trainees. Methods A voluntary, anonymous …

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

…, J Acheson, A Acosta, C Acton… - The …, 2022 - research.birmingham.ac.uk
… CA Green, Obbina Abani, Ali Abbas, Fatima Abbas, Mustafa Abbas, Sadia Abbasi, Hakam
Abbass, Alfie Abbott, Nabeel Abdallah, Ashraf Abdelaziz, Mohamed Abdelfattah, Bushra …